News for APEN Stock

BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FOURTH QUARTER AND FULL YEAR 2022 Apollo Endosurgery Announces Two Important Milestones in the Advancement of Endoscopic Procedures for Patients Living with Obesity Apollo Endosurgery to be Acquired by Boston Scientific Boston Scientific Announces Agreement to Acquire Apollo Endosurgery, Inc. Apollo Endosurgery to Participate in Upcoming Investor Conferences Apollo Endosurgery, Inc. Reports Record $19.6 million Global Revenue in Third Quarter 2022 Apollo Endosurgery to Report Third Quarter Results on November 1, 2022 Endoscopic Sleeve Gastroplasty (ESG) Procedure Featured as a "Top 10" Paper at the IFSO 2022 World Congress in Miami Apollo Endosurgery, Inc. Reports Record Global Revenue in Second Quarter 2022 Apollo Endosurgery Announces Publication in the Lancet of Landmark Study for the Endoscopic Sleeve Gastroplasty Procedure Apollo Endosurgery to Report Second Quarter Results on August 2, 2022 FDA Grants De Novo Marketing Authorization to Apollo Endosurgery for Apollo ESG(TM) and Apollo REVISE(TM), New Endoscopic Systems for Patients with Obesity Sharon O'Keefe Joins Apollo Endosurgery Board of Directors Digestive Disease Week 2022 Adds to the Growing Wave of Clinical Evidence Supporting Significant Opportunity for Apollo Endosurgery Products Apollo Endosurgery Products to Take Center Stage at Digestive Disease Week Apollo Endosurgery, Inc. Reports 33% U.S. Revenue Growth in First Quarter 2022 Apollo Endosurgery to Report First Quarter Results on May 3, 2022 Apollo Endosurgery Appoints Jeannette Bankes to Board of Directors Apollo Endosurgery to Participate in the Cowen Healthcare Conference Apollo Endosurgery, Inc. Reports 50% Revenue Growth in 2021 Apollo Endosurgery to Report Fourth Quarter and Full Year Results on February 22, 2022 Apollo Endosurgery Appoints Keely Scamperle as Vice President of Reimbursement and Market Access Apollo Endosurgery Announces Preliminary 2021 Revenue Results; Reflecting 50% Growth Over 2020 Apollo Endosurgery Announces New $100 Million Senior Secured Term Loan Facility from Innovatus Capital Partners, LLC Apollo Endosurgery to Present at Four Upcoming Investor Conferences Apollo Endosurgery, Inc. Reports 28% Revenue Growth in Third Quarter Conference Call and Webcast to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET Apollo Endosurgery Announces Publication of a Multicenter Study of Its X-Tack(R)Endoscopic HeliX Tacking System Apollo Endosurgery to Report Third Quarter Financial Results on November 1, 2021 Apollo Endosurgery Announces Positive MERIT-Trial Outcomes Apollo Endosurgery Announces Closing of Public Offering and Exercise in Full of Option to Purchase Additional Shares Apollo Endosurgery Announces Pricing of $65 Million Public Offering of Common Stock Apollo Endosurgery Announces Commencement of Public Offering of Common Stock Apollo Endosurgery Announces Preliminary Third Quarter 2021 Financial Results and Provides Business Updates Apollo Endosurgery to Present at Lake Street's 5th Annual Best Ideas Growth Conference Apollo Endosurgery, Inc. Reports Record Endoscopy Revenue in Second Quarter, Raises Full-Year Outlook Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET Apollo Endosurgery to Report Second Quarter Financial Results on August 3, 2021 Apollo Endosurgery Appoints Jeffrey G. Black as Chief Financial Officer MERIT Study Investigators Announce Successful Achievement of the Study's Primary Efficacy & Safety Endpoints Apollo Endosurgery to Present at June Investor Conferences Apollo Endosurgery's Innovative OverStitch(TM) Endoscopic Suturing System Highlighted During Digestive Disease Week 2021 Apollo Endosurgery to Present at Sidoti Conference May 20 Apollo Endosurgery, Inc. Reports 29% Increase in First Quarter Revenue Apollo Endosurgery Announces Appointments to Commercial Leadership Team Apollo Endosurgery to Report First Quarter Financial Results on May 4, 2021 Apollo Endosurgery Announces Publication of Pre-Clinical Results for X-Tack(TM) Endoscopic HeliX Tacking System Apollo Endosurgery Announces Inducement Grant Apollo Endosurgery announces AMA assignment of Category I CPT Codes for use in Intragastric Balloon Procedures Apollo Endosurgery to Present at HC Wainwright Global Life Sciences Conference Apollo Endosurgery Receives FDA Breakthrough Device Designation for the Orbera(R) Intragastric Balloon for Treatment of Patients with NASH Apollo Endosurgery, Inc. Reports Fourth Quarter and Full Year 2020 Results Apollo Endosurgery to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021 Apollo Endosurgery Announces CEO Transition Apollo Endosurgery to Present at HC Wainwright Bioconnect Conference Apollo Endosurgery Receives FDA Clearance for the X-Tack(TM) Endoscopic HeliX Tacking System Apollo Endosurgery Extends Maturity Date on Senior Secured Term Loan and Convertible Notes Apollo Endosurgery to Present at Piper Sandler Healthcare Conference Apollo Endosurgery, Inc. Reports Third Quarter 2020 Results Apollo Endosurgery to Present at November Investor Conferences Apollo Endosurgery, Inc. to Report Third Quarter 2020 Results on November 5, 2020 Apollo Endosurgery to Present at HC Wainwright Conference Apollo Endosurgery to Present at The LD 500 Virtual Conference